Novan (NASDAQ: NOVN)
Novan Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Novan Company Info
Novan, Inc. is a medical dermatology company, which engages in the development and commercialization of therapeutic products for skin diseases. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment involves the promotion of treatments for medical dermatology conditions products. The Research and Development Operations segment includes the development of nitric oxide-based technology products. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Durham, NC.
News & Analysis
Here's Why Novan Inc. Is Rising Today
The announcement that an important clinical program is moving forward has put investors in a good mood.
Why Novan Inc. Is Imploding Today
Shares collapsed after the company released disappointing results in one of its two phase 3 clinical trials.
Investors Wary on Noven Approval
The "tentative" status may be making investors jittery.
Monday's Worst Stocks in the World
It had to be someone.
Noven's Acquisition Blues
A recently acquired drug fails a late-stage clinical trial.
Noven's Novel Acquisition
With JDS Pharmaceuticals, the company is moving toward more traditional oral drugs.
Pay Attention to Noven
The company is smart with its money, but is relying on one drug for some time.
Noven Might Be in a Purple Patch
A new treatment for attention deficit disorder is selling so briskly, it could mean big money.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.